Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Ankr Network Ankr Network +23.17%
#3 BankrCoin BankrCoin +22.33%
#4 Status Status +14.60%
#5 ICON ICON +11.36%
#6 Siren Siren +8.94%
#7 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +6.96%
#8 Threshold Network Threshold Network +6.54%
#9 WAX WAX +6.54%
#10 would would +6.30%
Coin of the day
Palladium Network Palladium Network
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited

SHUKRAPHAR
Rang in Aktien #17792
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Aktienkurs
$0.51647906
Marktkapitalisierung
$226.16M
Veränderung (1 Tag)
5.29%
Veränderung (1 Jahr)
66.66%
Land
IN
Handel Shukra Pharmaceuticals Limited (SHUKRAPHAR)

Kategorie

Healthcare
Kursverlauf für Shukra Pharmaceuticals Limited (SHUKRAPHAR)
Höchster Schlusskurs: $0.50 am 2026-09-01

Niedrigster Schlusskurs: $0.01 am 2012-02-01
Kursverlauf der Aktie von Shukra Pharmaceuticals Limited von 2012 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -26.03%
2025 451.85%
2024 197.76%
2023 280.51%
2022 59.53%
2021 94.47%
2020 -21.67%
2019 26.89%
2018 -12.00%
2017 -47.44%
2016 27.70%
2015 -4.12%
2014 146.21%
2013 -72.65%
2012 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $62.82 71.36%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 $50.73 70.75%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 $197.97 44.74%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 $61.86 -2.57%
IT
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $0.67 -39.18%
HK